Literature DB >> 15753225

Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda.

Jane A Leopold, Elliott M Antman.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15753225     DOI: 10.1161/01.CIR.0000158691.22229.75

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

1.  Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis.

Authors:  Sergei Zaitsev; Kristina Danielyan; Juan-Carlos Murciano; Kumkum Ganguly; Tatiana Krasik; Ronald P Taylor; Steven Pincus; Steven Jones; Douglas B Cines; Vladimir R Muzykantov
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

Review 2.  Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.

Authors:  Monique P Curran; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Eptifibatide: The evidence for its role in the management of acute coronary syndromes.

Authors:  Ibrahim Shah; Shakeel O Khan; Surender Malhotra; Tim Fischell
Journal:  Core Evid       Date:  2010-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.